MedTrace Logo

A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial

NCT04183660 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2025-05-31

No results posted yet for this study

Summary

The purpose of this study is to evaluate prospectively the safety and performance of the MOBYBOX System in the veno-arterial configuration in patients with cardiorespiratory failure or in the veno-venous configuration in patients with severe respiratory failure.

Conditions

  • Cardiac Failure
  • Respiratory Failure
  • Cardio-Respiratory Failure
  • Imminent Cardiorespiratory or Respiratory Failure

Interventions

DEVICE

MOBYBOX System

extracorporeal cardiopulmonary support

Sponsors & Collaborators

  • seleon GmbH

    collaborator UNKNOWN

  • Hemovent GmbH

    lead INDUSTRY

Principal Investigators

  • Tienush Rassaf, Prof. · Uniklinikum Essen

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-30
Primary Completion
2026-04-30
Completion
2026-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04183660 on ClinicalTrials.gov